The store will not work correctly when cookies are disabled.
(4-benzylpiperazin-1-yl)(5-methyl-2-(pyridin-4-yl)phenyl)methanone
ID: ALA5288871
Max Phase: Preclinical
Molecular Formula: C24H25N3O
Molecular Weight: 371.48
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(-c2ccncc2)c(C(=O)N2CCN(Cc3ccccc3)CC2)c1
Standard InChI: InChI=1S/C24H25N3O/c1-19-7-8-22(21-9-11-25-12-10-21)23(17-19)24(28)27-15-13-26(14-16-27)18-20-5-3-2-4-6-20/h2-12,17H,13-16,18H2,1H3
Standard InChI Key: DAPHYEFOJQRXHP-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
16.0303 -2.5053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0291 -3.3303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7419 -3.7419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4562 -3.3298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4534 -2.5017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7401 -2.0938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7435 -4.5623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0294 -4.9728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0289 -5.7946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7417 -6.2069 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.4566 -5.7914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4536 -4.9709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7376 -1.2712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3165 -3.7410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3158 -4.5635 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.6044 -3.3292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.6045 -2.5024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8965 -2.0906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1814 -2.4978 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.1788 -3.3213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8912 -3.7376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4709 -2.0833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7567 -2.4913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0467 -2.0788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3330 -2.4862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3287 -3.3096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0442 -3.7241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7551 -3.3143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
3 7 1 0
6 13 1 0
2 14 1 0
14 15 2 0
14 16 1 0
16 17 1 0
16 21 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
19 22 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 371.48 | Molecular Weight (Monoisotopic): 371.1998 | AlogP: 4.02 | #Rotatable Bonds: 4 |
Polar Surface Area: 36.44 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 6.99 | CX LogP: 3.79 | CX LogD: 3.64 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.70 | Np Likeness Score: -1.31 |
References
1. Koike T, Yoshikawa M, Ando HK, Farnaby W, Nishi T, Watanabe E, Yano J, Miyamoto M, Kondo S, Ishii T, Kuroita T.. (2021) Discovery of Soticlestat, a Potent and Selective Inhibitor for Cholesterol 24-Hydroxylase (CH24H)., 64 (16.0): [PMID:34387987] [10.1021/acs.jmedchem.1c00864] |